Eficacia de la tafenoquina en la profilaxis y tratamiento de la malaria por Plasmodium vivax, revisión sistemática y metaanálisis

INTRODUCTION: Tafenoquine was approved in 2018 by the Food and Drug Administration in the United States and in 2019 by the Therapeutic Goods Administration in Australia. Its administration in a single dose and its mechanism of action in the acute and latent phases of the disease have been studied to...

Descripción completa

Detalles Bibliográficos
Autores principales: Cubillos, Astrid Lorena, Porras, Alexandra, Rico, Alejandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Instituto Nacional de Salud 2022
Materias:
Artículos Originales
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9451530/
https://www.ncbi.nlm.nih.gov/pubmed/35867928
http://dx.doi.org/10.7705/biomedica.5988

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9451530/
https://www.ncbi.nlm.nih.gov/pubmed/35867928
http://dx.doi.org/10.7705/biomedica.5988

Ejemplares similares